USFDA Approves Roche's Evrysdi Tablet for Spinal Muscular Atrophy Farhat Nasim15 Feb 2025 10:45 AM ISTEvrysdi is the only non-invasive disease-modifying treatment for SMA.
Multiple sclerosis may increase risk of mental illness during and after pregnancy, claims study Dr. Kamal Kant Kohli9 Feb 2025 8:15 PM ISTPeople with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other chronic conditions,...
Keto diet could one day treat autoimmune disorders, suggests research Dr. Kamal Kant Kohli28 Jan 2025 7:45 AM ISTScientists have long suspected the keto diet might be able to calm an overactive immune system and help some people with diseases like multiple...
Shilpa Pharma Lifesciences receives CEP from EDQM for API, Teriflunomide Ruchika Sharma24 Jan 2025 12:30 PM ISTKarnataka: Shilpa Pharma Lifesciences Limited, a 100 percent subsidiary of Shilpa Medicare Limited has received certificate of suitability (CEP)...
Medical Bulletin 15/ January/ 2025 Dr. Bhumika Maikhuri15 Jan 2025 3:00 PM ISTHere are the top medical news for the day:Computer Model as Guide for Treatment Selection in Chronic Myelogenous Leukemia: Study FindsResearchers, in...
Link Between Menopause and Faster Progression of Multiple Sclerosis in Women: UCSF Study Dr. Bhumika Maikhuri15 Jan 2025 8:30 AM ISTA new study by UC San Francisco has found that menopause revs up the progression of multiple sclerosis (MS). Following menopause, patients' walking...
COVID-19 infection not tied to worsening symptoms among MS patients: Study Dr. Kamal Kant Kohli24 Dec 2024 8:45 PM ISTFor people with multiple sclerosis (MS), having a COVID-19 infection is not associated with worsening MS symptoms or disability, according to a study...
Sanofi gets USFDA Breakthrough Therapy designation for multiple sclerosis therapy Tolebrutinib Ruchika Sharma17 Dec 2024 11:32 AM ISTParis: Sanofi has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to Tolebrutinib for the...
USFDA grants Breakthrough Therapy designation to Sanofi tolebrutinib for non-relapsing secondary progressive multiple sclerosis Ruchika Sharma13 Dec 2024 3:53 PM ISTParis: Sanofi has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to tolebrutinib...
Cutting early life exposure to parental smoking may lower MS risk in genetically prone, reveals study Dr. Kamal Kant Kohli12 Dec 2024 10:00 PM ISTCutting early life exposure to parental smoking may lower the risk of developing MS (multiple sclerosis) in those who are genetically predisposed to...
Medical Bulletin 30/ November/ 2024 Dr. Bhumika Maikhuri30 Nov 2024 3:00 PM ISTHere are the top medical news for the day:Long Term Hormone Therapy May Affect Metabolic Health of Transgender IndividualsNew research from Karolinska...
Can Low Advantage Neighborhood Lead to Worse Outcomes for Kids with MS? Study Finds Out Dr. Bhumika Maikhuri30 Nov 2024 8:15 AM ISTPeople who develop multiple sclerosis (MS) as children and grow up in less advantaged neighborhoods may have a larger volume of inflammation and brain...
